Actively Recruiting
Testing Two Tranexamic Acid Treatments Versus Placebo to Reduce Bleeding in Children 10 to 18 Years Having Surgery for Idiopathic Scoliosis
Led by Poznan University of Medical Sciences · Updated on 2026-07-01
90
Participants Needed
1
Research Sites
4 weeks
Total Duration
AI-Summary
What This Trial Is About
This research aims to evaluate whether tranexamic acid TXA, a medication used to reduce bleeding, is effective and safe in children aged 10 to 18 years undergoing surgery for idiopathic scoliosis. This surgery often involves significant blood loss and may require blood transfusions. The study compares two different intravenous TXA dosing strategies against a placebo to find the best approach for reducing blood loss and transfusion needs. Participants will be randomly assigned to one of three groups one group receives TXA as a 15 mgkg intravenous bolus followed by a continuous infusion during surgery another group receives two intravenous bolus doses of TXA at 10 mgkg each and the third group receives a placebo saline in the same volume and timing as the TXA groups. All patients will have standardized anesthesia, regional analgesia, and intraoperative neuromonitoring during the surgery. The maximum total TXA dose is limited to 2 grams. Participants will be followed for 30 days after surgery to monitor blood loss, transfusion volume, and laboratory measures such as hemoglobin and clotting factors. Safety will be assessed by tracking side effects including seizures and blood clots. Researchers will measure total blood loss within 24 hours after surgery as the primary outcome. The study includes detailed blood tests immediately after surgery and at 24 hours, with careful monitoring of patient health during the follow-up period.
CONDITIONS
Brief Title
Tranexamic Acid in Pediatric Idiopathic Scoliosis Surgery
Research Team
M
Malgorzata Reysner, MD PhD
P
Piotr Janusz, MD PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here